The market is pricing Lang & Schwarz as if its story ended with Trade Republic.
Redeye comments on Plejd’s Q3 report, which showed net sales of SEK282.
Redeye views I-Tech’s Q3 as showing healthy progress, with top-line growth of 19% and an EBITDA marg...
We view OHB’s share price weakness as unjustified given the further strengthening we expect in its o...
Sales -9% vs. ABGSCe, EBIT SEK 13m vs. ABGSCe 17m * Organic growth of 18%, strong gross margin 60% (...
Redeye updates on Invisio ahead of Q3-results (due 30 October) where we expect strong YoY growth aga...
* We forecast net sales of SEK 178m in Q3'26e * DTC-related cost ramp-up now in comps, EBITA +3% y-o...
Ahead of Atria's Q3 results, we trim 2026E-28E adjusted EBIT by 4-6% owing to the ASF outbreak in Fi...
* 16% organic growth in Q3e * Norwegian and UK users added, but revenue likely to land in Q4 * Conti...
* Early signs of stabilisation, but numbers lag * We lower '26e-'28e adj.
* Q3e: Sales of SEK 1,178m, adj. EBIT of SEK 46m * US demand backdrop remains robust * Trading at 11...
Coor väntas minska omsättningen med 1 procent till 2 975 mkr i Q3.
Redeye is positive to today's news where I-Tech announced that it has signed a license agreement wit...
Redeye keeps its positive view and forecasts for Avensia following Q3 sales figures.
* Order om 1,2 MSEK via nätverksförsäljning i USA * Tre frågor till vd Torsten Helsing * Vi behåller...
Modus has temporarily paused enrolment in part 2 of its phase IIa study of sevuparin in CKD with ana...
Duell's sales in Q4 were clearly ahead of our and consensus expectations, leading full-year sales ab...
Cicor released its Q1 2026 trading update. Q3 sales increased 6.
Dala Vind continues to consolidate ownership in its existing wind portfolio, following a smaller acq...
* Q3 volumes ahead of expectations * '26e EBIT up by 11% on higher volumes * We see a return to grow...